Local administration of ReveromycinA ointment suppressed alveolar bone loss in mice

• Main Authors: Ken Miyazawa (Author), Yuichiro Asano (Author), Masako Tabuchi (Author), Shunsuke Kako (Author), Makoto Kawatani (Author), Hiroyuki Osada (Author), Hatsuhiko Maeda (Author), Shigemi Goto (Author)
• Format: Book
• Published: Elsevier, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ReveromycinA (RMA) was developed and is a unique agent for inhibiting osteoclast activity. In a previous study, we experimentally induced periodontal disease in a high-turnover osteoporosis osteoprotegerin-knockout mice (OPG KO) model and found that intraperitoneal administration of RMA inhibited al...